Predicting Onset and Continuity of Patient-Reported Symptoms in Patients Receiving Immune Checkpoint Inhibitor (ICI) Therapies Using Machine Learning. Archives of Clinical and Medical Case Reports, v. 4, n. 3, p. 344–351, 5 May2020.